Goldan Keith A. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$44,522.25
Insider Sells Quantity
7
Insider Sells Sum
$94,916.75

Insider Activity of Goldan Keith A.

According to the SEC Form 4 filings, Goldan Keith A., being in a position of

  1. Chief Financial Officer at Syndax Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6669 shares for $136,988,
    over all time since 2023-06-13, has bought 4250 shares for $25,037, and sold 12319 shares for $220,452.

Biography of Goldan Keith A.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$136,9883100

Comparison of Insiders on Amount of Buys and Sells

2026-06-01SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
1,177
0.0013%
$18.99$22,351+1.22%
2026-02-09SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
3,410
0.0039%
$21.03$71,705-5.14%
2026-02-06SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
2,082
0.0024%
$20.62$42,931-4.26%
2025-07-16SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
1,296
0.0015%
$9.29$12,033+115.14%
2025-05-19PurchaseSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
3,000
–
$0$0+83.33%
2025-02-10SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
3,777
0.0044%
$15.50$58,559-2.51%
2024-06-14PurchaseSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
1,250
0.0015%
$20.03$25,037-22.23%
2023-06-13SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
577
0.0008%
$22.31$12,873-8.16%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.